Delivery Order SPE2DB20D1100-SPE2DB25FE1FG
- Not listed
- The Defense Logistics Agency awarded a $14,582.36 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed-price, non-set-aside contract with a completion date of July 31, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Descovy is an antiretroviral medication used in HIV prevention and treatment, and this delivery order represents a routine...
- The Defense Logistics Agency awarded a delivery order valued at $4,739.71 to AmerisourceBergen Drug Corp for Descovy 200-25 mg tablets (30-count units) on August 12, 2025, with an ultimate completion date of August 13, 2025. This competitive award, issued under firm fixed pricing with no set-aside designation, represents a pharmaceutical supply delivery from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania to the same location. Descovy is an antiretroviral medication used in...
- The Defense Logistics Agency awarded a $2,842.20 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by September 16, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Descovy is an antiretroviral medication used in HIV prevention and treatment,...
- The Defense Logistics Agency (DLA) awarded a $35,790.27 delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under the open market. The contract has an ultimate completion date of September 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Descovy is an...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 21, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $8,812.16 and an ultimate completion date of April 22, 2025. The contract was competitively awarded with no set-aside designation. Descovy is an antiretroviral medication used in HIV treatment and prevention, reflecting the critical pharmaceutical support...
- The Defense Logistics Agency awarded a $8,390.42 firm fixed price delivery order to AmerisourceBergen Drug Corp for 30 units of Descovy 200-25 mg tablets. The award, issued on April 28, 2025, with an ultimate completion date of April 29, 2025, represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office location. Descovy is an antiretroviral medication used in HIV treatment and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This order, valued at $7,045.86 under a firm fixed-price contract type, represents a non-competitive delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be fulfilled at AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $22,830.75 to AmerisourceBergen Drug Corp for 30-unit supplies of Descovy 200-25 mg tablets. This firm fixed-price, non-set-aside contract was executed on August 19, 2025, with an ultimate completion date of August 20, 2025, and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Descovy is an antiretroviral medication used in HIV prevention and treatment, reflecting the federal...
- The Defense Logistics Agency awarded a delivery order valued at $28,993.50 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed price contract with an ultimate completion date of September 10, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the contractor's demonstrated...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 tablets, with a ceiling value of $10,790.10 and an ultimate completion date of August 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE1FGDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Descovy 200-25 mg tablets (30-count units) with a ceiling value of $11,729.79 under a firm fixed-price contract. The award was made on September 25, 2025, with an ultimate completion date of September 26, 2025. This delivery order is not set-aside and represents a competitive award to the prime contractor, whose corporate office is located in Conshohocken, Pennsylvania. Descovy is an antiretroviral medication used in HIV prevention and treatment, reflecting the pharmaceutical supply needs of federal military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which has a potential value of $999,999,999.00 and extends through December 2026. That comprehensive prime vendor contract enables the company to supply a broad range of pharmaceutical products, vaccines, and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp's federal contract portfolio demonstrates its role as a critical pharmaceutical distributor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities through flexible contract vehicles designed to meet diverse medical procurement requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.7k | 9/25/25 |